The estimated Net Worth of Jonathon M Singer is at least 3.02 百万$ dollars as of 12 December 2018. Mr. Singer owns over 50,000 units of RTI Surgical stock worth over 831,610$ and over the last 8 years he sold RTIX stock worth over 0$. In addition, he makes 2,188,310$ as Chief Financial Officer、 Chief Operating Officer at RTI Surgical.
Sign up
Mr. Singer RTIX stock SEC Form 4 insiders trading
Jonathon has made over 2 trades of the RTI Surgical stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 50,000 units of RTIX stock worth 214,000$ on 12 December 2018.
The largest trade he's ever made was buying 50,000 units of RTI Surgical stock on 12 December 2018 worth over 214,000$. On average, Jonathon trades about 5,000 units every 54 days since 2016. As of 12 December 2018 he still owns at least 264,844 units of RTI Surgical stock.
You can see the complete history of Mr. Singer stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jonathon Singer biography
Jonathon M. Singer serves as Chief Financial Officer, Chief Operating Officer of the Company. He was named Chief Financial and Administrative Officer in September 2017, and Corporate Secretary in November 2017. Mr. Singer previously served as a member of the Board of Directors from May 2016 to September 2017. Mr. Singer previously served as Chief Financial Officer of Sagent Pharmaceuticals from 2011 until 2017, and was appointed Executive Vice President and Chief Financial Officer in March 2012. Mr. Singer was Senior Vice President, Treasurer, Secretary and Chief Financial Officer of Landauer, Inc. from 2006 to 2011. From 2004 to 2006, Mr. Singer served as Vice President of Global Finance and Chief Financial Officer of the Medial Segment for Teleflex Inc. Prior to 2004, Mr. Singer worked in various capacities for R.R. Donnelley & Sons Company, Cardinal Health Inc., and KPMG LLP. Mr. Singer is a certified public accountant and received a Bachelor’s Degree in Business Administration from Miami University in Ohio and a Master’s Degree from Northwestern University’s Kellogg Graduate School of Management.
What is the salary of Jonathon Singer?
As the Chief Financial Officer、 Chief Operating Officer of RTI Surgical, the total compensation of Jonathon Singer at RTI Surgical is 2,188,310$. There are no executives at RTI Surgical getting paid more.
How old is Jonathon Singer?
Jonathon Singer is 55, he's been the Chief Financial Officer、 Chief Operating Officer of RTI Surgical since 2020. There are 5 older and 5 younger executives at RTI Surgical. The oldest executive at RTI Surgical Holdings, Inc. is Thomas McEachin, 67, who is the Independent Director.
What's Jonathon Singer's mailing address?
Jonathon's mailing address filed with the SEC is 520 LAKE COOK ROAD, SUITE 315, DEERFIELD, IL, 60015.
Insiders trading at RTI Surgical
Over the last 21 years, insiders at RTI Surgical have traded over 71,830$ worth of RTI Surgical stock and bought 390,515 units worth 1,973,594$ . The most active insiders traders include Jeffrey C Lightcap、Mark Stolper、Terry M. Rich. On average, RTI Surgical executives and independent directors trade stock every 138 days with the average trade being worth of 62,561$. The most recent stock trade was executed by Jonathon M Singer on 12 December 2018, trading 50,000 units of RTIX stock currently worth 214,000$.
What does RTI Surgical do?
RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.
What does RTI Surgical's logo look like?
Complete history of Mr. Singer stock trades at RTI Surgical
RTI Surgical executives and stock owners
RTI Surgical executives and other stock owners filed with the SEC include:
-
Jonathon Singer,
Chief Financial Officer, Chief Operating Officer -
John Varela,
Executive Vice President - Global Operations -
Olivier Visa,
Vice President - OEM, Sports and Donor Services -
Shirley Weis,
Independent Director -
Thomas McEachin,
Independent Director -
Mark Stolper,
Lead Independent Director -
Paul Thomas,
Independent Director -
Nicholas Valeriani,
Independent Director -
Pawel Lewicki,
Director -
Scott Durall,
Chief Commercial Officer -
Bryan Cornwall,
Executive Vice President - Research and Clinical Affairs -
Stuart Simpson,
Chairman of the Board -
Molly Poarch,
Director, Corporate Communications & Investor Relations -
Jeffrey Lightcap,
Independent Director -
Brian Kushner,
Director -
Ryan Bartolucci,
Vice President - Finance, Corporate Controller -
Terry Rich,
President, Chief Executive Officer, Director -
Lyle P. Luedeman,
-
Dean H Bergy,
Director -
Street Healthcare Partners ...,
-
Christopher R Sweeney,
Director -
Curtis M Selquist,
Director -
Peter F Gearen,
Director -
Brian K Hutchison,
Chairman, President and CEO -
Camille Farhat,
Chief Executive Officer -
Robert P Jordheim,
Executive Vice President/CFO -
Roger W Rose,
Vice President Donor Services -
Johannes Wynand Louw,
Vice President Finance -
Kevin D Brandt,
EVP CCO-Domestic Direct -
Joshua H De Rienzis,
General Counsel -
Philip R Chapman,
Director -
Ned Hoye Villers,
Director -
Adrian J R Smith,
Director -
Caroline A Hartill,
V.P. Quality Assurance -
Julianne M Bowler,
Director -
Roy D Crowninshield,
Director -
Gregory P Rainey,
Director -
Neal B Freeman,
Director -
Michael J La Prade,
Vice President -
Holdings Inc Zimmer,
10% owner -
Roderick N Allen,
Vice President -
David J Simpson,
Director -
Guy L Mayer,
President -
Michael J Odrich,
Director -
Lee Robert Jr Johnston,
Vice President -
Udo Henseler,
Director -
Christie J Blakely,
Vice President -
Robert J Lane,
Vice President -
Tara Leigh Zerby,
VP, Xenograft Technologies -
Carolyn Shaffer,
Vice President, Human Resource -
Thomas F Rose,
Vice President and CFO -
Michael T Manley,
Director -
Louis E Barnes,
Vice President-Cardiovascular -
Charles Randal Mills,
V.P. of Business Development -
William Melendez,
Vice President, Research & Dev -
Jeffrey Michael Schumm,
Vice Pres. and General Counsel -
Joseph W Condon,
Vice President-Operations